Contrast Sensitivity and Diabetic Macular Edema
1 other identifier
observational
132
1 country
1
Brief Summary
Contrast sensitivity is a tool use to evaluate the visual function in all patients. It can be modified by different pathologies or by age. The purpose of this study is to identify the changes that could be in relationship with the course of diabetic retinopathy comparing with diabetic patient without retinopathy and in patients with diabetic macular edema so if it is a difference, research for therapeutic strategies to improve it in this patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 6, 2014
CompletedFirst Posted
Study publicly available on registry
August 15, 2014
CompletedAugust 15, 2014
August 1, 2014
6 months
August 6, 2014
August 13, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Contrast Sensitivity
Diabetic patients who are attended at Ophthalmology service in a general hospital undergo to contrast sensitivity test evaluating all frequency by software with 5 spacial frequency (1.5, 3, 6, 12 and 18 cycle grade, Stereoptical Co 1996) in the Visual Basic program.
up to 8 months
Study Arms (1)
Contrast Sensitivity
Determine changes in contrast sensitivity frequences and visual function (visual acuity) after one month of treatment photocoagulation in macular edema
Eligibility Criteria
Diabetic patients attended at Ophthalmology service in a general hospital
You may qualify if:
- DIABETIC PATIENTS
- YEARS OLD
- ANY GENDER
- VISUAL ACUITY \>0.25 IN DECIMAL EQUIVALENT,
You may not qualify if:
- PATIENTS WITH CATARACTS OR OTHER MACULOPATHY
- PATIENTS WITH CONTACT LENSES
- PATIENTS WITH REFRACTIVE ERROR \>6.00DP
- PATIENTS WITH PREVIOUS OCULAR SURGERY
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Juarez de Mexico
Mexico City, Mexico City, 07760, Mexico
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
DULCE MI RAZO BLANCO HERNANDEZ, MD
Hospital Juarez de Mexico
- STUDY CHAIR
SURISADAI SERAFIN SOLIS, MSc
INSTITUTO POLITECNICO NACIONAL
- STUDY CHAIR
LOURDES CA ORTEGA LUNA, MSc
INSTITUTO POLITECNICO NACIONAL
- STUDY DIRECTOR
VIRGILIO LIMA GOMEZ, MD, MSc
Hospital Juarez de Mexico
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MEDICAL RESEARCHER
Study Record Dates
First Submitted
August 6, 2014
First Posted
August 15, 2014
Study Start
January 1, 2014
Primary Completion
July 1, 2014
Study Completion
August 1, 2014
Last Updated
August 15, 2014
Record last verified: 2014-08